The American Hospital Association argues new policies from Eli Lilly and Novo Nordisk requiring providers to submit more claims data on dispensed 340B drugs is onerous and unlawful.
WCIA Champaign on MSN
Illinois faith leaders challenge hospitals over 340B Drug Program
SPRINGFIELD, Ill. (WCIA) — Faith and community leaders gathered in Springfield on Wednesday to call for increased oversight ...
On February 2, 2024, the “gang of six”—a bipartisan group of six senators who have traditionally championed reforms to the 340B program 1 —introduced a discussion draft of a bill that would modify the ...
Axios on MSN
Health care advocates say FSSA's proposed drug program change will erode Indiana's safety net
Indiana wants to discontinue Medicaid reimbursement for drugs purchased under a federal program designed to help hospitals afford to care for low-income patients. Why it matters: The move will save ...
Senator calls on Congress to increase oversight of the 340B Drug Pricing Program by requiring participating providers to complete annual reports on program savings and revenues. If your health system ...
The drug industry and hospitals have been butting heads over the future of a federal drug pricing program for more than a year, according to The Washington Post. Federal regulators may finalize ...
The Patient Protection and Affordable Care Act is expected to bring significant change to the healthcare industry, including the expansion of the Public Health Service Act Section 340B Program.
In a move that will fundamentally change how the 340B Drug Pricing Program (“340B Program”) operates for a subset of medications, HRSA’s Office of Pharmacy Affairs (“OPA”) opted late last week to ...
Amid ongoing controversy over 340B drug discounts, a sweeping review suggests the program is doing what it was intended to do: generate revenue for hospitals, clinics and pharmacies by requiring ...
In August, J&J informed disproportionate share hospitals, which care for a large number of vulnerable patients, that it would stop giving them upfront discounts on plaque psoriasis treatment Stelara ...
Congress needs to act to bring needed reforms into the 340B to make revenue from the drug pricing program more transparent and to ensure patients are benefiting from the discounts, according to a ...
PHILADELPHIA, PA, UNITED STATES, February 4, 2026 /EINPresswire.com/ — RxParadigm, an end-to-end 340B drug administration platform with integrated capabilities to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results